These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17625134)

  • 61. [IGA concentration in serum, sputum and bronchoalveolar lavage in chronic bronchitis].
    Schultek T; Braun J; Wiessmann KJ; Wood WG
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1611-4. PubMed ID: 3665748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gamma delta T cells in asthma.
    Rossman MD; Carding SR
    Ann Intern Med; 1996 Jan; 124(2):266-7. PubMed ID: 8534005
    [No Abstract]   [Full Text] [Related]  

  • 63. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.
    Vijayanand P; Seumois G; Pickard C; Powell RM; Angco G; Sammut D; Gadola SD; Friedmann PS; Djukanovic R
    N Engl J Med; 2007 Apr; 356(14):1410-22. PubMed ID: 17409322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Invariant natural killer T cells in obstructive pulmonary diseases.
    Heron M; Claessen AM; Grutters JC
    N Engl J Med; 2007 Jul; 357(2):194; author reply 194-5. PubMed ID: 17626309
    [No Abstract]   [Full Text] [Related]  

  • 65. Invariant natural killer T cells in obstructive pulmonary diseases.
    Bratke K; Julius P; Virchow JC
    N Engl J Med; 2007 Jul; 357(2):194; author reply 194-5. PubMed ID: 17632897
    [No Abstract]   [Full Text] [Related]  

  • 66. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.
    Akbari O; Faul JL; Hoyte EG; Berry GJ; Wahlström J; Kronenberg M; DeKruyff RH; Umetsu DT
    N Engl J Med; 2006 Mar; 354(11):1117-29. PubMed ID: 16540612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bronchoalveolar lavage in bronchial asthma].
    Soja J; Gross-Sondej I; Sładek K
    Pneumonol Alergol Pol; 2003; 71(9-10):458-63. PubMed ID: 15052982
    [No Abstract]   [Full Text] [Related]  

  • 68. Role of bronchoalveolar lavage in the investigation of cell-mediated defence mechanisms against lung cancer.
    Spatafora M; Merendino AM; Chiappara G; Melis M; Volpes D; Bellia V; Bonsignore G
    Eur Respir J; 1990 Mar; 3(3):370-1. PubMed ID: 2187710
    [No Abstract]   [Full Text] [Related]  

  • 69. [Lymphocytes in bronchoalveolar lavage (BAL). Why are kinetic parameters for interpretation of BAL findings important for the patient?].
    Pabst R; Tschernig T
    Pneumologie; 1998 Mar; 52(3):128-31. PubMed ID: 9564185
    [No Abstract]   [Full Text] [Related]  

  • 70. Invariant natural killer T cells in obstructive pulmonary diseases.
    Akbari O; Faul JL; Umetsu DT
    N Engl J Med; 2007 Jul; 357(2):193-4; author reply 194-5. PubMed ID: 17625134
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.